drugset / Trial / NCT02503865

Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome

NCT02503865

RandomizedParallel-groupOpen-labelTreatment

Summary

Metabolic syndrome: aetiology, pathogenesis, diagnosis, clinical management and prognosis

Timeline

Start
2003-01
Primary completion
2008-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 40 mg
Comparator Diltiazem Small molecule 90 mg
Comparator Lizinopril Unknown 20 mg
Comparator Orlistat Small molecule 120 mg
Comparator Pioglitazone Small molecule 30 mg

Indications